(Q44146572)

30 November 2017

The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer (English)

1 reference

30 November 2017

Jorge A. Carrasquillo

3

1 reference

30 November 2017

David N Danforth

1

1 reference

30 November 2017

Luigi Aloj

2

1 reference

30 November 2017

Stephen L Bacharach

4

1 reference

30 November 2017

Cathy Chow

5

1 reference

30 November 2017

JoAnne Zujewski

6

1 reference

30 November 2017

Millie Whatley

7

1 reference

30 November 2017

Barbara Galen

8

1 reference

30 November 2017

Maria Merino

9

1 reference

30 November 2017

Ronald D Neumann

10

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Breast Cancer Research and Treatment

30 November 2017

1 reference

30 November 2017

75

1 reference

30 November 2017

135-146

1 reference

30 November 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1019664126220

30 November 2017

0 references

cites work

Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

Imaging of axillary lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast Disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Diagnostic value of positron emission tomography for detecting breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Skeletal metastases from breast cancer: uptake of 18F-fluoride measured with positron emission tomography in correlation with CT

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Comparison of intraoperative frozen section analysis of sentinel node with preoperative positron emission tomography in the diagnosis of axillary lymph node status in breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019664126220

7 January 2021

Identifiers

DOI

10.1023/A:1019664126220

1 reference

Dimensions Publication ID

30 November 2017

0 references

1 reference